Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Feb 16, 2018 3:11pm
337 Views
Post# 27574467

RE:RE:RE:RE:RE:It's Friday shorties ! better cover before the weekend,

RE:RE:RE:RE:RE:It's Friday shorties ! better cover before the weekend,
Stockman,  youre not alone, there are a lot of people who feel that way.    But IF the US Bankers are right about the logic of hanging on to the IP as the carrot to attract big money backers....   then how else do you fund the burn and  trials  ?   As I said, you can just proceed on the hope that the Voucher comes in time ?  or do another ugly Cdn equity raise or another US Pipe ?   

Here's what your logic is missing in my opinion.    Over the last 3-6 months....Pierre and Bruce have gotten meaningful traction  amongst the NYork IB's and with Roche and Boehringer with respect to the importance and crediblity of the 4050 and analogue program.    To the degree that they are beginning to get respect for what they have, and the fact that its woefully undervalued still.

The quickest path to unlocking that value is through a US listing....   and ironically the quickest path to getting to your Cdn $5 share target...is via a Nasdaq list in the short term followed by a large and comprehensive worldwide IPF deal.
Bullboard Posts